Closeup hands of old woman suffering from leprosy, for article on leprosy elimination

Jordan becomes first country to receive WHO verification for eliminating leprosy

For the first time in history, a country has been officially verified as having eliminated leprosy. The World Health Organization confirmed that Jordan has met the threshold, marking a milestone that public health officials say could reshape how the world approaches one of its oldest known diseases.

At a glance

  • Leprosy elimination: Jordan has not reported a single locally transmitted case of leprosy in over two decades, prompting WHO to commission an independent verification team to review the evidence.
  • Hansen’s disease: Caused by the bacterium Mycobacterium leprae, this chronic infection affects the skin, peripheral nerves, and eyes — and can cause permanent disability if left untreated.
  • WHO verification: After an extensive independent review, the team recommended WHO formally acknowledge Jordan’s elimination status, making Jordan the first country in the world to receive this designation.

What elimination actually means

Leprosy still affects more than 120 countries worldwide. Over 200,000 new cases are reported every year, mostly in South Asia, sub-Saharan Africa, and parts of Latin America. Against that backdrop, Jordan’s achievement stands out sharply.

Elimination, in WHO terms, means the interruption of local transmission — no new cases originating within the country. Jordan crossed that threshold more than 20 years ago and has maintained it since. The verification process required an independent team to confirm the data, assess surveillance systems, and review public health infrastructure before WHO could officially make the call.

That rigor matters. The designation is not symbolic — it reflects a sustained, system-level commitment rather than a lucky gap in reporting.

Decades of sustained effort

Jordan’s success did not happen quickly. It required consistent political will, strong coordination between the Ministry of Health and WHO, and surveillance systems capable of catching cases — including those originating abroad — before any local chain of transmission could begin.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus noted that leprosy has “afflicted humanity for millennia,” and that progress is only coming country by country, through exactly this kind of deliberate, long-term effort. Saima Wazed, WHO Regional Director for South-East Asia and head of the Global Leprosy Programme, framed the fight as more than medical: “It is also a fight against stigma, and a fight against psychological and socio-economic harm.”

That framing reflects something important about leprosy’s history. The disease has carried severe social stigma for thousands of years, leading to isolation, discrimination, and shame for those diagnosed. Eliminating transmission also means dismantling the conditions that made that stigma possible in the first place.

A model for other countries

WHO Regional Director for the Eastern Mediterranean Dr. Hanan Balkhy said Jordan’s status as the first verified country “will transform the discourse around this age-old, stigmatizing disease” and serve as an inspiration to other nations still working toward elimination.

The precedent matters in practical terms. Jordan has demonstrated that a country with limited resources — and in a region that has faced significant public health challenges — can reach and hold this threshold through coordination, surveillance, and commitment. That model is replicable.

WHO Representative to Jordan Dr. Jamela Al-Raiby pointed to the partnership between the Ministry of Health and WHO at all three organizational levels — country, regional, and global — as a key factor in making this work. That kind of multi-level collaboration is exactly the architecture needed to take leprosy elimination global.

The work that remains

Both WHO and Jordan’s Ministry of Health are clear that verification is not the end of the road. Robust surveillance systems must stay in place to detect and manage any future cases, including those that might arrive from abroad. As long as leprosy persists in other countries, the risk of importation remains real — and the response to any such case must be swift and non-discriminatory.

More than 200,000 new leprosy cases are still diagnosed globally each year, and the burden falls disproportionately on some of the world’s poorest communities. Jordan’s achievement is meaningful, but the global picture is still far from resolved.

Still, the direction is clear. Early diagnosis and treatment can prevent the disabilities that made leprosy so feared for so long. And now, for the first time, the world has proof that a country can reach the finish line.

Read more

For more on this story, see: World Health Organization

For more from Good News for Humankind, see:

About this article

  • 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
  • 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
  • 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
  • ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.


More Good News

  • Scientist filling tubes, for article on reversible male contraception

    Cornell researchers achieve first reversible male birth control in mice

    Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across…


  • Lakes, for article on coal mine restoration

    Germany finishes 60-year project turning coal mines into a 23-lake district

    Germany’s Lusatian Lakeland is now complete — a chain of 23 human-made lakes covering 14,000 hectares where open-cast coal mines once scarred the land between Berlin and Dresden. The final piece, Lake Sedlitz, opened to swimmers and boaters this April, and in June, five of the lakes will be linked by navigable canals into a continuous 5,000-hectare waterway. Engineers spent decades channeling river water into the old craters, securing embankments, and flushing out acid — work that would have taken nature a century. The region now welcomes around 800,000 overnight stays a year, with former miners finding work in hospitality…


  • People holding breast cancer pin, for article on vitamin D breast cancer

    Brazilian researchers find vitamin D boosts breast cancer chemo by 79%

    Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful…



Coach, writer, and recovering hustle hero. I help purpose-driven humans do good in the world in dark times - without the burnout.